Evonik’s AMINODat® 6.2 now includes latest US Crop Report
- The US Crop Report provides state-specific data for corn and soybean meal
- Essential source showing trends affecting crops from the US
- Demonstration of Evonik’s commitment to deliver key feed quality services
Essen, Germany. Evonik released its newest edition of the US Crop Report which has been integrated into AMINODat® 6.2, the world’s most comprehensive animal nutrition database. The US Crop Report provides state-specific data for corn and soybean meal, exclusively from the US, and marks a significant enhancement of Evonik's service offerings in animal nutrition.
Integrated into Evonik’s AMINODat® 6.2 database, the 2023 US Crop Report is an essential resource for customers in the animal feed industry, demonstrating Evonik’s commitment to deliver key feed quality services.
"The release of this report is not just about numbers and data; it is about the trends and variables affecting the crops that are the lifeblood of our industry. Every sample analyzed and every trend identified represents a collective effort between Evonik and our customers. It's the story of partnership and progress," says Victor Naranjo, Regional Technical Director at Evonik’s Animal Nutrition business line.
AMINODat® 6.2, published in January, has become the most comprehensive animal nutrition database in the world. By providing access to over 600,000 feed ingredient samples and 31 million analytical results, AMINODat® 6.2 serves as a powerful tool for optimizing feed formulations and enhancing quality control, ensuring the well-being and performance of animals.
The 2023 US Crop Report demonstrates the collaborative relationship between Evonik and its customers. It requires a shared commitment to quality and a dedication to advancing the industry.
For more information please visit the website at evonik.click/aminodat.
Company information
Evonik is one of the world leaders in specialty chemicals. The company is active in more than 100 countries around the world and generated sales of €15.3 billion and an operating profit (adjusted EBITDA) of €1.66 billion in 2023. Evonik goes far beyond chemistry to create innovative, profitable, and sustainable solutions for customers. More than 33,000 employees work together for a common purpose: We want to improve life today and tomorrow.
About Nutrition & Care
The focus of the business of the Nutrition & Care division is on health and quality of life. It develops differentiated solutions for active pharmaceutical ingredients, medical devices, nutrition for humans and animals, personal care, cosmetics, and household cleaning. In these resilient end markets, the division generated sales of €3.61 billion in 2023 with more than 5,600 employees.
Disclaimer
In so far as forecasts or expectations are expressed in this press release or where our statements concern the future, these forecasts, expectations or statements may involve known or unknown risks and uncertainties. Actual results or developments may vary, depending on changes in the operating environment. Neither Evonik Industries AG nor its group companies assume an obligation to update the forecasts, expectations or statements contained in this release.